关注
Aldostefano Porcari
Aldostefano Porcari
Cardiologist, PhD Fellow
在 nhs.net 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cardiac tumors: diagnosis, prognosis, and treatment
R Bussani, M Castrichini, L Restivo, E Fabris, A Porcari, F Ferro, A Pivetta, ...
Current cardiology reports 22, 1-13, 2020
1272020
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies
A Aimo, M Merlo, A Porcari, G Georgiopoulos, L Pagura, G Vergaro, ...
European journal of heart failure 24 (12), 2342-2351, 2022
992022
Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years
A Ioannou, RK Patel, Y Razvi, A Porcari, G Sinagra, L Venneri, F Bandera, ...
Circulation 146 (22), 1657-1670, 2022
742022
Transthyretin cardiac amyloidosis
A Porcari, M Fontana, JD Gillmore
Cardiovascular Research 118 (18), 3517-3535, 2022
652022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from phase 2 of the AC‐TIVE study, an Italian nationwide survey
M Merlo, L Pagura, A Porcari, M Cameli, G Vergaro, B Musumeci, ...
European Journal of Heart Failure 24 (8), 1377-1386, 2022
652022
Restrictive cardiomyopathy: definition and diagnosis
C Rapezzi, A Aimo, A Barison, M Emdin, A Porcari, A Linhart, A Keren, ...
European heart journal 43 (45), 4679-4693, 2022
642022
Transthyretin amyloid cardiomyopathy: an uncharted territory awaiting discovery
A Porcari, M Merlo, C Rapezzi, G Sinagra
European Journal of Internal Medicine 82, 7-15, 2020
492020
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios
A Porcari, C Baggio, E Fabris, M Merlo, R Bussani, A Perkan, G Sinagra
Heart Failure Reviews 28 (1), 123-135, 2023
452023
Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosis
A Porcari, M Rossi, F Cappelli, M Canepa, B Musumeci, A Cipriani, G Tini, ...
European Journal of Heart Failure 24 (7), 1227-1236, 2022
422022
Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
L Chacko, N Karia, L Venneri, F Bandera, BD Passo, L Buonamici, ...
European Journal of Heart Failure 24 (9), 1700-1712, 2022
382022
Prevalence, characteristics and outcomes of older patients with hereditary versus wild‐type transthyretin amyloid cardiomyopathy
A Porcari, Y Razvi, A Masi, R Patel, A Ioannou, MU Rauf, DF Hutt, ...
European Journal of Heart Failure 25 (4), 515-524, 2023
372023
Incidence and characterization of concealed cardiac amyloidosis among unselected elderly patients undergoing post-mortem examination
A Porcari, R Bussani, M Merlo, GG Varrà, L Pagura, D Rozze, G Sinagra
Frontiers in Cardiovascular Medicine 8, 749523, 2021
372021
Low QRS voltages in cardiac amyloidosis: clinical correlates and prognostic value
A Cipriani, L De Michieli, A Porcari, L Licchelli, G Sinigiani, G Tini, ...
Cardio Oncology 4 (4), 458-470, 2022
362022
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology
U Vespasiani-Gentilucci, P Gallo, F Piemonte, E Riva, A Porcari, F Vorini, ...
PLoS One 11 (5), e0156113, 2016
352016
Sex differences among patients with transthyretin amyloid cardiomyopathy–from diagnosis to prognosis
RK Patel, A Ioannou, Y Razvi, L Chacko, L Venneri, F Bandera, D Knight, ...
European Journal of Heart Failure 24 (12), 2355-2363, 2022
342022
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis
MU Rauf, PN Hawkins, F Cappelli, F Perfetto, M Zampieri, A Argiro, ...
European Heart Journal 44 (24), 2187-2198, 2023
332023
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques
A Porcari, G De Angelis, S Romani, A Paldino, J Artico, A Cannatà, ...
Expert Review of Cardiovascular Therapy 17 (1), 53-63, 2019
332019
Value of the HFA‐PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis
D Tomasoni, A Aimo, M Merlo, M Nardi, M Adamo, MG Bellicini, D Cani, ...
European Journal of Heart Failure 24 (12), 2374-2386, 2022
322022
Viral presence‐guided immunomodulation in lymphocytic myocarditis: an update
G Sinagra, A Porcari, P Gentile, J Artico, E Fabris, R Bussani, M Merlo
European Journal of Heart Failure 23 (2), 211-216, 2021
312021
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and …
M Merlo, A Porcari, L Pagura, M Cameli, G Vergaro, B Musumeci, ...
European Journal of Preventive Cardiology 29 (5), e173-e177, 2022
302022
系统目前无法执行此操作,请稍后再试。
文章 1–20